ACXP insider transactions
Acurx Pharmaceuticals Inc. (ACXP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ACXP
- SEC Form 4 filed by Sailer Carl4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Dean Jack H4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Donohue James J.4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Harrison Thomas L4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Scodari Joseph C4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Deluccia Robert J4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Luci David P4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Shawah Robert G.4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Shawah Robert G.4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by President and CEO Luci David P4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Director Deluccia Robert J4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- Director Scodari Joseph C bought $25,000 worth of shares (24,631 units at $1.01), increasing direct ownership by 800% to 27,708 units (SEC Form 4)4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- Director Sailer Carl bought $25,000 worth of shares (24,631 units at $1.01), increasing direct ownership by 22% to 137,183 units (SEC Form 4)4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- President and CEO Luci David P bought $50,000 worth of shares (49,261 units at $1.01), increasing direct ownership by 5% to 1,097,458 units (SEC Form 4)4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- Director Donohue James J. bought $10,000 worth of shares (9,852 units at $1.01), increasing direct ownership by 79% to 22,352 units (SEC Form 4)4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- Director Deluccia Robert J bought $50,000 worth of shares (49,261 units at $1.01), increasing direct ownership by 5% to 1,010,196 units (SEC Form 4)4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- Director Dean Jack H bought $10,000 worth of shares (9,852 units at $1.01), increasing direct ownership by 83% to 21,776 units (SEC Form 4)4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Director Scodari Joseph C4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Director Sailer Carl4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Director Harrison Thomas L4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Director Donohue James J.4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Director Dean Jack H4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Shawah Robert G.4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Luci David P4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Deluccia Robert J4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- Sailer Carl exercised 19,737 shares at a strike of $3.55, increasing direct ownership by 21% to 112,552 units (SEC Form 4)4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- Deluccia Robert J gifted 110,000 shares and exercised 19,737 shares at a strike of $3.55, decreasing direct ownership by 9% to 960,935 units (SEC Form 4)4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- Luci David P exercised 19,737 shares at a strike of $3.55, increasing direct ownership by 2% to 1,048,197 units (SEC Form 4)4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Donohue James J.4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Harrison Thomas L4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Sailer Carl4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Dean Jack H4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Scodari Joseph C4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Luci David P4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Shawah Robert G.4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4 filed by Deluccia Robert J4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4: Sailer Carl bought $75,001 worth of shares (19,737 units at $3.80), increasing direct ownership by 27% to 92,815 units4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4: Deluccia Robert J bought $75,001 worth of shares (19,737 units at $3.80), increasing direct ownership by 2% to 1,051,198 units4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4: Luci David P bought $75,001 worth of shares (19,737 units at $3.80), increasing direct ownership by 2% to 1,028,460 units4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4: Sailer Carl bought $24,979 worth of shares (5,161 units at $4.84), increasing direct ownership by 8% to 73,078 units4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4: Deluccia Robert J bought $24,672 worth of shares (5,034 units at $4.90), increasing direct ownership by 0.49% to 1,031,461 units4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4: Luci David P bought $24,960 worth of shares (5,200 units at $4.80), increasing direct ownership by 0.52% to 1,008,723 units4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
- SEC Form 4: Sailer Carl bought $75,000 worth of Common Stock (12,500 units at $6.00), increasing direct ownership by 23% to 67,917 units4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)